# Pro-Dex share price today (Pro-Dex, Inc., PDEX)

> Pro-Dex, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. PDEX · Healthcare · Medical Instruments & Supplies · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/pdex

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $60.24 (+66.2% in a year)
- P/E: 16.6×, over 1 year
- Revenue (Jun 2026): $20.4 M (+16.6% on a year ago)
- Profit (Jun 2026): $2.9 M (+138.7% on a year ago)
- Operating margin: 17.3% (+9.6 points on a year ago)
- ROE: 29%, FY26
- ROIC: 18.9%, against a 4.4% cost of capital: +14.5 points

The main question: profits are rising, but only 48% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Pro-Dex share price today? Pro-Dex, Inc.'s share price was $60.24 at the close on 3 November 2026. That is 6.2% above its average price over the last 200 trading days. In the last 52 weeks it traded between $31 and $73, and at that close it sat 69% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 2 weeks running. Over the last 1 year the share price moved +34% while the S&P 500 moved +21%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Pro-Dex pay? Pro-Dex, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Pro-Dex on? Pro-Dex is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Pro-Dex profitable? Pro-Dex, Inc. earned $2.9 M of net profit in the Jun 2026 quarter, +138.7% on the same quarter a year earlier. That is the 4th quarter in a row of profit growth. Full-year FY26 profit was $13.7 M. Over 5 years profit has grown 17.2% a year on average. That is 14.0% of the quarter's revenue. The same quarter a year earlier earned $1.2 M. 1 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was $13.7 M (+52.2% on the year before). Why profit moved: revenue changed +16.6% on a year earlier and the margin moved +9.6 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +64.0% and revenue +16.7%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Pro-Dex make, and is it growing? Pro-Dex, Inc. reported $20.4 M of revenue in the Jun 2026 quarter, +16.6% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 5 years it has grown 15.3% a year on average. The last full year, FY26, came in at $77.5 M. The last four reported quarters add to $77.5 M. FY26 revenue was $77.5 M, +16.5% on the year before. Recent pace: the last four quarters grew +16.7% on average, against 15.3% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +16.4%, against +20.0% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +52.2%, against +153.4% a year (rolling over). ## How much of every $100 of sales does Pro-Dex keep? Pro-Dex, Inc.'s operating margin was 17.3% in the Jun 2026 quarter, 9.6 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 6 years it has been between 11.9% and 16.8%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +9.6 percentage points on the year while gross margin changed +14.8 points. So the gain came mostly from the gross margin, which means input costs and prices charged. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Pro-Dex's profit turning into cash? Over the last 3 years, 48% of Pro-Dex, Inc.'s reported profit came in as cash from its operations, a gap worth watching. In FY26 it brought in $7.2 M of operating cash against $13.7 M of profit. After $483 K of spending on assets, $6.8 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Pro-Dex's cash go? Pro-Dex, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $2.7 M on assets over the last 3 years. Averaged over those years that is 1.2% of FY26 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $2.7 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Pro-Dex's P/E ratio, and how does it compare with its own history? Pro-Dex, Inc.'s P/E is 16.6×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +54.3% while the price moved +66.2%. The price did better than earnings, which pushed the multiple up within its own range. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Pro-Dex business getting better or worse? Pro-Dex, Inc.'s business is giving mixed signals. Growth is slowing from a very fast pace: profit growth has eased from +322.1% at its peak to +52.2%, but the business is still expanding, with ROCE rising at 24.8%. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Pro-Dex earn on its capital? Pro-Dex, Inc. earned a ROE of 29% in FY26. That is up from a low of 7% in FY24. Its return on capital used (ROIC) is 14.5 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 17.6% net margin and 1.04× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 17.6% net margin × 1.04× asset turnover × 1.56× leverage (assets divided by equity) ≈ 28.6% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 18.9% − 4.4% = +14.5 percentage points. The 4.4% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. ## Does Pro-Dex have too much debt? Pro-Dex, Inc. has total debt of $18.9 M against shareholder equity of $47.6 M as of Jun 2026, so its debt is 0.40× its equity. Year by year, that ratio went from 0.76 in FY21 to 0.40 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Pro-Dex shareholding pattern? 15.8% of Pro-Dex, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 4.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Pro-Dex from balance-sheet trouble? For Pro-Dex, Inc., the Z-score is 6.70. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 6.70 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Pro-Dex rank in its industry? There is no score against its industry: Pro-Dex, Inc. is not among the largest members shown in this industry comparison for Medical Instruments & Supplies. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Pro-Dex compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Pro-Dex in size? Pro-Dex is the 37th largest of 38 Medical Instruments & Supplies companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: AngioDynamics, Inc., Embecta Corp., Sanara MedTech Inc., OraSure Technologies, Inc. and Utah Medical Products, Inc. Just below it: Anbio Biotechnology. ### Medical Instruments & Supplies companies close in size

1. [AngioDynamics, Inc.](https://www.sectoralpha.in/us/stocks/ango) $493 million
2. [Embecta Corp.](https://www.sectoralpha.in/us/stocks/embc) $344 million
3. [Sanara MedTech Inc.](https://www.sectoralpha.in/us/stocks/smti) $296 million
4. [OraSure Technologies, Inc.](https://www.sectoralpha.in/us/stocks/osur) $243 million
5. [Utah Medical Products, Inc.](https://www.sectoralpha.in/us/stocks/utmd) $222 million
6. Pro-Dex, Inc. $193 million
7. [Anbio Biotechnology](https://www.sectoralpha.in/us/stocks/nnnn) $157 million

[All 38 Medical Instruments & Supplies companies, largest first](https://www.sectoralpha.in/us/sectors/medical-instruments-supplies#all-companies)

## What else do people ask about Pro-Dex? ### What were Pro-Dex's latest quarterly results? Pro-Dex, Inc. reported revenue of $20.4 M and net profit of $2.9 M for the Jun 2026 quarter. Revenue rose 16.6% and profit rose 138.7% compared with a year earlier. Earnings per share were $0.87. The operating margin was 17.3%, 9.6 percentage points higher than a year earlier (as of 3 November 2026). ### What is Pro-Dex's market cap? Pro-Dex, Inc.'s market capitalisation is $193 M at a stock price of $60.24. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Pro-Dex performing? Pro-Dex, Inc.'s latest readings are below. In its latest quarter, revenue rose 16.6% and profit rose 138.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 2 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Pro-Dex's stock price go up? This page does not forecast Pro-Dex, Inc.'s stock price. What it shows instead: the stock price is $60.24. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Does Pro-Dex have too much debt? Pro-Dex, Inc. has a moderate amount of debt: its debt is 0.38× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is Pro-Dex in its business cycle? Pro-Dex, Inc.'s FY26 operating margin was 16.8%, against a 6-year range of 11.9% to 16.8%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 17.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Pro-Dex story? The main question: profits are rising, but only 48% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Pro-Dex a stock worth studying right now? What the numbers show: Pro-Dex, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.